Pub Date : 2026-12-01Epub Date: 2026-02-14DOI: 10.1080/01652176.2026.2628724
Erik van Engelen, Miriam Koene, Robert Jan Molenaar, Annet Heuvelink
Spotty liver disease in laying hens can be caused by Campylobacter hepaticus or by Campylobacter bilis. While C. hepaticus is widely distributed around the world, C. bilis has thus far only been documented in Australia and the USA. We investigated five outbreaks of spotty liver disease in laying hens in the Netherlands. In November 2020 C. bilis was cultured as the causal agent of the outbreak on one of these farms, while C. hepaticus was cultured from hens from the four other farms. Clinical and pathological features were indistinguishable, but MALDI-TOF and WGS identified these species unambiguously. To our knowledge, this is the first report of C. bilis outside Oceania and the USA.
{"title":"<i>Campylobacter bilis</i> caused spotty liver syndrome in laying hens in the Netherlands.","authors":"Erik van Engelen, Miriam Koene, Robert Jan Molenaar, Annet Heuvelink","doi":"10.1080/01652176.2026.2628724","DOIUrl":"10.1080/01652176.2026.2628724","url":null,"abstract":"<p><p>Spotty liver disease in laying hens can be caused by <i>Campylobacter hepaticus</i> or by <i>Campylobacter bilis</i>. While <i>C. hepaticus</i> is widely distributed around the world, <i>C. bilis</i> has thus far only been documented in Australia and the USA. We investigated five outbreaks of spotty liver disease in laying hens in the Netherlands. In November 2020 <i>C. bilis</i> was cultured as the causal agent of the outbreak on one of these farms, while <i>C. hepaticus</i> was cultured from hens from the four other farms. Clinical and pathological features were indistinguishable, but MALDI-TOF and WGS identified these species unambiguously. To our knowledge, this is the first report of <i>C. bilis</i> outside Oceania and the USA.</p>","PeriodicalId":51207,"journal":{"name":"Veterinary Quarterly","volume":"46 1","pages":"2628724"},"PeriodicalIF":5.2,"publicationDate":"2026-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12912234/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146196166","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-12-01Epub Date: 2026-01-06DOI: 10.1080/01652176.2025.2603307
Janne Snoeck, Xiaole Cui, Pieter Vervaeke, Niek N Sanders, An Garmyn
Vaccination is routinely used in industrial poultry to control infectious diseases. Vaccines based on mRNA and self-amplifying RNA (saRNA) are approved for human use, but research on their application in poultry is limited. In this study the saRNA vaccine platform is evaluated in poultry. First, a luciferase-encoding saRNA (luc-saRNA) was tested as a model vaccine across different administration routes and doses in broilers. High luciferase expression, and anti-luciferase antibodies were observed after intramuscular (IM), subcutaneous (SC), and in ovo (IO) administration. After a second Luc-saRNA injection, seroconversion rates and antibody titers increased in the IM and SC group to almost 100%. Higher doses of Luc-saRNA increased luciferase production. However, they did not linearly increase antibody production, as all tested doses (0.20-5.0 µg) elicited an equipotent immune response. A vaccination experiment with saRNA encoding the hemagglutinin head-domain (HA-HD) of H5N1 avian influenza showed hemagglutinin inhibition (HI) titers that are indicative for protection after a single injection and these titers remained above the protective threshold during 6 weeks without boosting. When boosted, the HI titers increased four-fold. This study confirms effective protein translation and immune response induction in chickens with IM or SC administered saRNA-LNPs, even at the lowest dose of 0.20 µg.
{"title":"Influence of the administration route and dose on the expression and antibody responses of a reporter and avian influenza self-amplifying mRNA vaccine in poultry.","authors":"Janne Snoeck, Xiaole Cui, Pieter Vervaeke, Niek N Sanders, An Garmyn","doi":"10.1080/01652176.2025.2603307","DOIUrl":"10.1080/01652176.2025.2603307","url":null,"abstract":"<p><p>Vaccination is routinely used in industrial poultry to control infectious diseases. Vaccines based on mRNA and self-amplifying RNA (saRNA) are approved for human use, but research on their application in poultry is limited. In this study the saRNA vaccine platform is evaluated in poultry. First, a luciferase-encoding saRNA (luc-saRNA) was tested as a model vaccine across different administration routes and doses in broilers. High luciferase expression, and anti-luciferase antibodies were observed after intramuscular (IM), subcutaneous (SC), and in ovo (IO) administration. After a second Luc-saRNA injection, seroconversion rates and antibody titers increased in the IM and SC group to almost 100%. Higher doses of Luc-saRNA increased luciferase production. However, they did not linearly increase antibody production, as all tested doses (0.20-5.0 µg) elicited an equipotent immune response. A vaccination experiment with saRNA encoding the hemagglutinin head-domain (HA-HD) of H5N1 avian influenza showed hemagglutinin inhibition (HI) titers that are indicative for protection after a single injection and these titers remained above the protective threshold during 6 weeks without boosting. When boosted, the HI titers increased four-fold. This study confirms effective protein translation and immune response induction in chickens with IM or SC administered saRNA-LNPs, even at the lowest dose of 0.20 µg.</p>","PeriodicalId":51207,"journal":{"name":"Veterinary Quarterly","volume":"46 1","pages":"2603307"},"PeriodicalIF":5.2,"publicationDate":"2026-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12781945/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145913575","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-12-01Epub Date: 2026-02-09DOI: 10.1080/01652176.2026.2622732
Marisa Esteves-Monteiro, Margarida Duarte-Araújo, Clara Landolt, Cláudia S Baptista
Diagnostic ultrasound (US) is a noninvasive, cost-effective imaging modality widely used for evaluating the gastrointestinal (GI) tract in companion animals. It provides information on wall thickness and layer differentiation, allowing assessment of normal anatomy and pathological changes. Despite its diagnostic relevance, ultrasonographic reference values for the GI tract in dogs and cats remain inconsistent across publications. This study reviewed ultrasonographic characteristics of the normal GI wall in dogs and cats and compiled a consensus-based reference table for overall wall thickness and individual layer proportions to enhance clinical interpretation. A literature search of PubMed and Scopus identified studies assessing the ultrasonographic features of normal GI segments, from stomach to colon, in healthy dogs and cats. Twelve studies met the inclusion criteria: six focused on dogs and six on cats. Reference values for GI wall thickness and its layers were reported in both species. However, discrepancies were noted in weight-based classifications for dogs, and the stomach of adult dogs remains poorly studied. Moreover, evaluation of gastric rugal and inter-rugal folds remains limited in this species. US is valuable for GI assessment, but dispersion of reference values across studies may hinder accessibility. Establishing standardized ultrasonographic parameters could improve diagnostic accuracy and clinical decision-making.
{"title":"Ultrasonographic evaluation of the normal gastrointestinal wall in dogs and cats: a systematic review on study design and imaging outcomes.","authors":"Marisa Esteves-Monteiro, Margarida Duarte-Araújo, Clara Landolt, Cláudia S Baptista","doi":"10.1080/01652176.2026.2622732","DOIUrl":"10.1080/01652176.2026.2622732","url":null,"abstract":"<p><p>Diagnostic ultrasound (US) is a noninvasive, cost-effective imaging modality widely used for evaluating the gastrointestinal (GI) tract in companion animals. It provides information on wall thickness and layer differentiation, allowing assessment of normal anatomy and pathological changes. Despite its diagnostic relevance, ultrasonographic reference values for the GI tract in dogs and cats remain inconsistent across publications. This study reviewed ultrasonographic characteristics of the normal GI wall in dogs and cats and compiled a consensus-based reference table for overall wall thickness and individual layer proportions to enhance clinical interpretation. A literature search of PubMed and Scopus identified studies assessing the ultrasonographic features of normal GI segments, from stomach to colon, in healthy dogs and cats. Twelve studies met the inclusion criteria: six focused on dogs and six on cats. Reference values for GI wall thickness and its layers were reported in both species. However, discrepancies were noted in weight-based classifications for dogs, and the stomach of adult dogs remains poorly studied. Moreover, evaluation of gastric rugal and inter-rugal folds remains limited in this species. US is valuable for GI assessment, but dispersion of reference values across studies may hinder accessibility. Establishing standardized ultrasonographic parameters could improve diagnostic accuracy and clinical decision-making.</p>","PeriodicalId":51207,"journal":{"name":"Veterinary Quarterly","volume":"46 1","pages":"2622732"},"PeriodicalIF":5.2,"publicationDate":"2026-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12888347/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146144545","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-12-01Epub Date: 2026-01-19DOI: 10.1080/01652176.2026.2616395
Aleksandra Synowiec, Magdalena Pachota, Martyna Krejmer-Rabalska, Daria Ziemann, Krzysztof Szczubiałka, Michal Jank, Lukasz Rabalski, Maria Nowakowska, Jerzy P Gawor, Krzysztof Pyrć
Feline calicivirus (FCV) infection causes nasal discharge, oral mucosa inflammation, ulcerations, gingivitis, and conjunctivitis, often progressing to chronic gingivostomatitis, severe pneumonia, and fatal systemic infections. With no antivirals currently available, poly(sodium 4-styrene sulfonate) (PSSNa) was identified in 2019 as a safe inhibitor in vitro. In this preliminary single-center, randomized, double-blind, placebo-controlled field study, we further characterized the PSSNa's safety profile and tested its efficacy in cats after topical oral application. Twenty-eight cats were enrolled in the study, and they were initially treated with standard dental therapy, followed by adjuvant local oral application of PSSNa or placebo. After 4 weeks, PSSNa demonstrated a favorable safety profile with no adverse effects. The treatment group showed a significant decrease in viral load (p = 0.001) compared to placebo (p = 0.012). Disease symptoms improved significantly, though the oral health index remained unchanged. Additionally, PSSNa showed activity against multiple genetically diverse isolates, indicating a potential, exploratory link between genetic background and treatment outcome. Summarizing, this study presents initial data on the efficacy and tolerability of PSSNa treatment for FCV infections in cats. Nevertheless, several significant limitations should be acknowledged, including inconsistent drug administration by owners, non-sterile housing, sample size, variable oral disease severity, and concurrent treatments.
{"title":"Antiviral effect of poly(styrene 4-sulfonate) (PSSNa) on feline calicivirus oral infections in cats-field study.","authors":"Aleksandra Synowiec, Magdalena Pachota, Martyna Krejmer-Rabalska, Daria Ziemann, Krzysztof Szczubiałka, Michal Jank, Lukasz Rabalski, Maria Nowakowska, Jerzy P Gawor, Krzysztof Pyrć","doi":"10.1080/01652176.2026.2616395","DOIUrl":"10.1080/01652176.2026.2616395","url":null,"abstract":"<p><p>Feline calicivirus (FCV) infection causes nasal discharge, oral mucosa inflammation, ulcerations, gingivitis, and conjunctivitis, often progressing to chronic gingivostomatitis, severe pneumonia, and fatal systemic infections. With no antivirals currently available, poly(sodium 4-styrene sulfonate) (PSSNa) was identified in 2019 as a safe inhibitor <i>in vitro</i>. In this preliminary single-center, randomized, double-blind, placebo-controlled field study, we further characterized the PSSNa's safety profile and tested its efficacy in cats after topical oral application. Twenty-eight cats were enrolled in the study, and they were initially treated with standard dental therapy, followed by adjuvant local oral application of PSSNa or placebo. After 4 weeks, PSSNa demonstrated a favorable safety profile with no adverse effects. The treatment group showed a significant decrease in viral load (<i>p</i> = 0.001) compared to placebo (<i>p</i> = 0.012). Disease symptoms improved significantly, though the oral health index remained unchanged. Additionally, PSSNa showed activity against multiple genetically diverse isolates, indicating a potential, exploratory link between genetic background and treatment outcome. Summarizing, this study presents initial data on the efficacy and tolerability of PSSNa treatment for FCV infections in cats. Nevertheless, several significant limitations should be acknowledged, including inconsistent drug administration by owners, non-sterile housing, sample size, variable oral disease severity, and concurrent treatments.</p>","PeriodicalId":51207,"journal":{"name":"Veterinary Quarterly","volume":"46 1","pages":"2616395"},"PeriodicalIF":5.2,"publicationDate":"2026-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12818315/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145999615","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Staphylococcus aureus (S. aureus) evades host immunity by modulating macrophage functions, including immune regulation and phagocytosis, ultimately contributing to bovine mastitis. This study aimed to elucidate the molecular mechanisms of S. aureus-induced bovine mastitis from both host and pathogen perspectives, focusing on prostaglandin E2 (PGE2) as a key regulator. During bovine mastitis, macrophages were recruited into the mammary gland with elevated inflammatory mediators. S. aureus lipoproteins amplified inflammation by activating MAPK and NF-κB pathways via TLR2, TLR4, and NLRP3, leading to elevated secretion of mediators, including PGE2, in bBMMs. Inhibition of TLR2, TLR4, or NLRP3 decreased COX-2 and mPGES-1 expression, suppressing PGE2 synthesis, while inhibition of COX-2 or mPGES-1 can regulate the expression of TLR2 and NLRP3, as well as the activation of MAPKs and NF-κB signaling pathways. Excess PGE2 can regulate inflammation and phagocytosis mediated by TLR2, TLR4, and NLRP3. S. aureus lipoproteins promote PGE2 synthesis via TLR2, TLR4, and NLRP3 signaling, while PGE2, in turn, modulates receptor activity, inflammation, and phagocytosis. These findings reveal crucial functional cross-talk between PGE2 and innate immune receptors in S. aureus-induced mastitis, suggesting that targeting this interaction may provide novel therapeutic strategies.
{"title":"An underlying mechanism of bovine mastitis: PGE<sub>2</sub> regulates <i>Staphylococcus aureus</i>-induced inflammatory response through TLR2, TLR4, and NLRP3 in macrophages.","authors":"Zhiguo Gong, Zhuoya Yu, Peipei Ren, Shuangyi Zhang, Ruifeng Gao, Jiamin Zhao, Yixin Wang, Shaojie Qin, Wenhui Bao, Feng Shuang","doi":"10.1080/01652176.2026.2615759","DOIUrl":"10.1080/01652176.2026.2615759","url":null,"abstract":"<p><p><i>Staphylococcus aureus</i> (<i>S. aureus</i>) evades host immunity by modulating macrophage functions, including immune regulation and phagocytosis, ultimately contributing to bovine mastitis. This study aimed to elucidate the molecular mechanisms of <i>S. aureus</i>-induced bovine mastitis from both host and pathogen perspectives, focusing on prostaglandin E<sub>2</sub> (PGE<sub>2</sub>) as a key regulator. During bovine mastitis, macrophages were recruited into the mammary gland with elevated inflammatory mediators. <i>S. aureus</i> lipoproteins amplified inflammation by activating MAPK and NF-κB pathways <i>via</i> TLR2, TLR4, and NLRP3, leading to elevated secretion of mediators, including PGE<sub>2</sub>, in bBMMs. Inhibition of TLR2, TLR4, or NLRP3 decreased COX-2 and mPGES-1 expression, suppressing PGE<sub>2</sub> synthesis, while inhibition of COX-2 or mPGES-1 can regulate the expression of TLR2 and NLRP3, as well as the activation of MAPKs and NF-κB signaling pathways. Excess PGE<sub>2</sub> can regulate inflammation and phagocytosis mediated by TLR2, TLR4, and NLRP3. <i>S. aureus</i> lipoproteins promote PGE<sub>2</sub> synthesis <i>via</i> TLR2, TLR4, and NLRP3 signaling, while PGE<sub>2</sub>, in turn, modulates receptor activity, inflammation, and phagocytosis. These findings reveal crucial functional cross-talk between PGE<sub>2</sub> and innate immune receptors in <i>S. aureus</i>-induced mastitis, suggesting that targeting this interaction may provide novel therapeutic strategies.</p>","PeriodicalId":51207,"journal":{"name":"Veterinary Quarterly","volume":"46 1","pages":"2615759"},"PeriodicalIF":5.2,"publicationDate":"2026-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12818336/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145991815","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-12-01Epub Date: 2026-01-12DOI: 10.1080/01652176.2025.2607418
Josiah Levi Davidson, Murali Kannan Maruthumuthu, Mohamed Kamel, Suraj Mohan, Ana Pascual-Garrigos, Andres Dextre, Ruth Eunice Centeno-Delphia, Jacquelyn P Boerman, Deepti Pillai, Jennifer Koziol, Aaron Ault, Jon P Schoonmaker, Timothy A Johnson, Mohit S Verma
Herein, we present novel quantitative loop-mediated isothermal amplification (qLAMP) and reverse-transcription qLAMP (RT-qLAMP) assays for the detection of five viruses implicated with the onset and progression of bovine respiratory disease (BRD): Bovine Alphaherpesvirus Type 1 (BHV-1), Bovine Adenovirus Type 3 (BAV-3), Bovine Respiratory Syncytial Virus (BRSV), Bovine Viral Diarrhea Virus Type 1 (BVDV-1), and Bovine Parainfluenza Virus Type 3 (BPIV-3). Using contrived samples spiked with whole viruses, our extraction-free assays have limits of detection between 30 and 1,057 copies per reaction (1.8% final sample concentration) with minimal sample processing. Using dual-tipped swabs and 1.4 mL resuspension volumes, limits of detection are on the order of 2 × 105 copies per swab for BAV-3 and BHV-1 and between 6.31 × 106 to 8.22 × 106 copies per swab for BPIV-3, BRSV, and BVDV-1. Analytical sensitivities ranged from 73 - 100% and analytical specificities ranged from 90 - 100%. Additionally, we introduced a streamlined pipeline to minimize the experimental workload to design, screen, select, and characterize LAMP performance for developing assays. Our assays support the development of colorimetric LAMP assays that enable the sensitive and specific detection of these viruses' chute side to aid in diagnosing and treating BRD. The associated pipeline enables more rapid development of LAMP-based diagnostic tools targeting emerging pathogens.
{"title":"Detection of five viruses commonly implicated with bovine respiratory disease using loop-mediated isothermal amplification.","authors":"Josiah Levi Davidson, Murali Kannan Maruthumuthu, Mohamed Kamel, Suraj Mohan, Ana Pascual-Garrigos, Andres Dextre, Ruth Eunice Centeno-Delphia, Jacquelyn P Boerman, Deepti Pillai, Jennifer Koziol, Aaron Ault, Jon P Schoonmaker, Timothy A Johnson, Mohit S Verma","doi":"10.1080/01652176.2025.2607418","DOIUrl":"10.1080/01652176.2025.2607418","url":null,"abstract":"<p><p>Herein, we present novel quantitative loop-mediated isothermal amplification (qLAMP) and reverse-transcription qLAMP (RT-qLAMP) assays for the detection of five viruses implicated with the onset and progression of bovine respiratory disease (BRD): Bovine Alphaherpesvirus Type 1 (BHV-1), Bovine Adenovirus Type 3 (BAV-3), Bovine Respiratory Syncytial Virus (BRSV), Bovine Viral Diarrhea Virus Type 1 (BVDV-1), and Bovine Parainfluenza Virus Type 3 (BPIV-3). Using contrived samples spiked with whole viruses, our extraction-free assays have limits of detection between 30 and 1,057 copies per reaction (1.8% final sample concentration) with minimal sample processing. Using dual-tipped swabs and 1.4 mL resuspension volumes, limits of detection are on the order of 2 × 10<sup>5</sup> copies per swab for BAV-3 and BHV-1 and between 6.31 × 10<sup>6</sup> to 8.22 × 10<sup>6</sup> copies per swab for BPIV-3, BRSV, and BVDV-1. Analytical sensitivities ranged from 73 - 100% and analytical specificities ranged from 90 - 100%. Additionally, we introduced a streamlined pipeline to minimize the experimental workload to design, screen, select, and characterize LAMP performance for developing assays. Our assays support the development of colorimetric LAMP assays that enable the sensitive and specific detection of these viruses' chute side to aid in diagnosing and treating BRD. The associated pipeline enables more rapid development of LAMP-based diagnostic tools targeting emerging pathogens.</p>","PeriodicalId":51207,"journal":{"name":"Veterinary Quarterly","volume":"46 1","pages":"2607418"},"PeriodicalIF":5.2,"publicationDate":"2026-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12798664/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145953580","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Managing fat accumulation is a critical goal in the poultry industry, with the liver being the primary site for lipid metabolism in chickens. This study used non-targeted metabolomics to investigate dynamic changes in metabolite composition in chicken liver across five physiological stages. A total of 1121 metabolites were identified, with 749 and 372 detected in positive- and negative-ion modes, respectively. The regulation of hepatic lipolysis involves numerous metabolic pathways, making it a complex process. We performed trend analysis of lipid, carbohydrate and amino acid-related metabolites. Age exerted major effects on hepatic metabolism, significantly enriching pathways including alpha-linolenic acid metabolism, linoleic acid metabolism, steroid hormone biosynthesis, 2-oxocarboxylic acid metabolism and nicotinate and nicotinamide metabolism. Transcriptomic analysis identified 12 lipid-metabolism-related genes, showing a tendency of continuously increase. Potential functional genes influencing lipid metabolism-related pathways were identified through a comprehensive analysis of differential lipid-related metabolites and genes, including fatty acid desaturase 2 (FADS2), acetyl-CoA acetyltransferase 2 (ACAT2), apovitellenin 1 (APOV1), vitellogenin 1 (VTG1), membrane-bound O-acyltransferase domain-containing protein 2 (MBOAT2) and ELOVL fatty acid elongase 1 (ELOVL1). These findings could help improve understanding of hepatic metabolism during different physiological stages and identify valuable biomarkers for specific metabolite accumulation.
{"title":"Integrative metabolomic and transcriptomic analysis reveals stage-specific shifts in hepatic lipid metabolism of broiler chickens.","authors":"Jingjing Li, Yidan Xu, Peng Ren, Xia Xiong, Mohan Qiu, Chunlin Yu, Yiping Liu, Chaowu Yang","doi":"10.1080/10495398.2026.2622124","DOIUrl":"10.1080/10495398.2026.2622124","url":null,"abstract":"<p><p>Managing fat accumulation is a critical goal in the poultry industry, with the liver being the primary site for lipid metabolism in chickens. This study used non-targeted metabolomics to investigate dynamic changes in metabolite composition in chicken liver across five physiological stages. A total of 1121 metabolites were identified, with 749 and 372 detected in positive- and negative-ion modes, respectively. The regulation of hepatic lipolysis involves numerous metabolic pathways, making it a complex process. We performed trend analysis of lipid, carbohydrate and amino acid-related metabolites. Age exerted major effects on hepatic metabolism, significantly enriching pathways including alpha-linolenic acid metabolism, linoleic acid metabolism, steroid hormone biosynthesis, 2-oxocarboxylic acid metabolism and nicotinate and nicotinamide metabolism. Transcriptomic analysis identified 12 lipid-metabolism-related genes, showing a tendency of continuously increase. Potential functional genes influencing lipid metabolism-related pathways were identified through a comprehensive analysis of differential lipid-related metabolites and genes, including <i>fatty acid desaturase 2</i> (<i>FADS2</i>), <i>acetyl-CoA acetyltransferase 2</i> (<i>ACAT2</i>), <i>apovitellenin 1</i> (<i>APOV1</i>), <i>vitellogenin 1</i> (<i>VTG1</i>), <i>membrane-bound O-acyltransferase domain-containing protein 2</i> (<i>MBOAT2</i>) <i>and ELOVL fatty acid elongase 1</i> (<i>ELOVL1</i>). These findings could help improve understanding of hepatic metabolism during different physiological stages and identify valuable biomarkers for specific metabolite accumulation.</p>","PeriodicalId":7836,"journal":{"name":"Animal Biotechnology","volume":"37 1","pages":"2622124"},"PeriodicalIF":1.8,"publicationDate":"2026-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12875106/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146111878","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-12-01Epub Date: 2026-02-11DOI: 10.1007/s44463-025-00004-1
Joyce Jen Li Lim, Nyuk Ling Chin, Chun Wie Chong, Adiratna Mat Ripen, Syahmeer How, Sze Qi Teoh
Kefir is a trending and highly valued fermented beverage known for its beneficial microbes and giving a wide spectrum of health benefits. It includes milk kefir and water kefir which have gained separate attention. Although milk kefir is more heard of than water kefir, it is essential to understand both in greater details in terms of similarities and differences. The key health benefits such as probiotics, protection in the gastrointestinal tract, control of glucose level, antioxidant, antimutagenic, anticarcinogenic, regulating cholesterol, antimicrobial and improving lactose digestion are discussed and supported with recent in-vivo or in-vitro scientific evidences. This review addresses the gap of individual focus of each kefir by direct comparison of its microbial diversity, processing and physicochemical qualities. It provides updated information on lactic acid bacteria by species from advanced techniques of metagenomic analysis and also highlights the potential of kefiran, exopolysaccharides of milk kefir grains in food, biopharmaceutical and packaging industries.
{"title":"Review on kefir beverages from milk and water: health benefits, processing and applications.","authors":"Joyce Jen Li Lim, Nyuk Ling Chin, Chun Wie Chong, Adiratna Mat Ripen, Syahmeer How, Sze Qi Teoh","doi":"10.1007/s44463-025-00004-1","DOIUrl":"https://doi.org/10.1007/s44463-025-00004-1","url":null,"abstract":"<p><p>Kefir is a trending and highly valued fermented beverage known for its beneficial microbes and giving a wide spectrum of health benefits. It includes milk kefir and water kefir which have gained separate attention. Although milk kefir is more heard of than water kefir, it is essential to understand both in greater details in terms of similarities and differences. The key health benefits such as probiotics, protection in the gastrointestinal tract, control of glucose level, antioxidant, antimutagenic, anticarcinogenic, regulating cholesterol, antimicrobial and improving lactose digestion are discussed and supported with recent in-vivo or in-vitro scientific evidences. This review addresses the gap of individual focus of each kefir by direct comparison of its microbial diversity, processing and physicochemical qualities. It provides updated information on lactic acid bacteria by species from advanced techniques of metagenomic analysis and also highlights the potential of kefiran, exopolysaccharides of milk kefir grains in food, biopharmaceutical and packaging industries.</p>","PeriodicalId":12459,"journal":{"name":"Food Science of Animal Resources","volume":"46 1","pages":"31"},"PeriodicalIF":3.7,"publicationDate":"2026-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12977308/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147443156","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-12-01Epub Date: 2026-02-03DOI: 10.1007/s44463-025-00003-2
Jinmo Park, Da-Young Lee, Ermie Jr Mariano, Yeongwoo Choi, Dahee Han, Jin Soo Kim, Ji Won Park, Seok Namkung, Seung Yun Lee, Hye Won Lee, Hyo Jin Lee, Sun Jin Hur
The industrialization of cultured meat requires not only the mass production of cells but also the development of alternative materials to serum, which is the most expensive of the required media constituents. Through a literature review, this paper investigates the potential of spinach-derived phytoecdysteroids (PEs) as a substitute for fetal bovine serum (FBS). PEs are analogs of ecdysteroids, insect-molting hormones synthesized by many plant species to defend against insects. PEs have been shown to stimulate protein synthesis in mammalian skeletal muscle, primarily through Akt activation, leading to increased muscle mass and fiber size. And PEs also inhibit collagenolytic enzyme activity, which may contribute to improved cell culture efficiency. Therefore, PEs may be utilized as a partial replacement of FBS for cultured meat production or as a material to increase cell culture efficiency. However, the in vivo effects of PEs on muscle protein synthesis may be limited by factors such as bioavailability and metabolic half-life, and further studies are needed.
{"title":"Review of culture media and serum substitutes containing phytoecdysteroids for application in cultured meat technology.","authors":"Jinmo Park, Da-Young Lee, Ermie Jr Mariano, Yeongwoo Choi, Dahee Han, Jin Soo Kim, Ji Won Park, Seok Namkung, Seung Yun Lee, Hye Won Lee, Hyo Jin Lee, Sun Jin Hur","doi":"10.1007/s44463-025-00003-2","DOIUrl":"https://doi.org/10.1007/s44463-025-00003-2","url":null,"abstract":"<p><p>The industrialization of cultured meat requires not only the mass production of cells but also the development of alternative materials to serum, which is the most expensive of the required media constituents. Through a literature review, this paper investigates the potential of spinach-derived phytoecdysteroids (PEs) as a substitute for fetal bovine serum (FBS). PEs are analogs of ecdysteroids, insect-molting hormones synthesized by many plant species to defend against insects. PEs have been shown to stimulate protein synthesis in mammalian skeletal muscle, primarily through Akt activation, leading to increased muscle mass and fiber size. And PEs also inhibit collagenolytic enzyme activity, which may contribute to improved cell culture efficiency. Therefore, PEs may be utilized as a partial replacement of FBS for cultured meat production or as a material to increase cell culture efficiency. However, the in vivo effects of PEs on muscle protein synthesis may be limited by factors such as bioavailability and metabolic half-life, and further studies are needed.</p>","PeriodicalId":12459,"journal":{"name":"Food Science of Animal Resources","volume":"46 1","pages":"1"},"PeriodicalIF":3.7,"publicationDate":"2026-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12977311/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147443248","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-12-01Epub Date: 2026-02-02DOI: 10.1080/01652176.2026.2622742
Juliette Poujol de Molliens, Carla Palacios-Gorba, Jazmin Meza-Torres, Jesús Gomis, Angel Gómez-Martín, Juan J Quereda
The genus Listeria is heterogeneous and contains pathogenic and nonpathogenic species. Pathogenic L. monocytogenes and L. ivanovii have different environmental distributions, infect different hosts, and cause distinct syndromes. Here, we evaluated whether responses of different Listeria species to diverse host niches contribute to virulence heterogeneity and influence their environmental distribution. We assessed resistance to gastric and intestinal fluids, gut and uterus microbiota, and semen. L. monocytogenes was more resistant than L. ivanovii in gastric fluid, whilst L. seeligeri and L. valentina showed an intermediate phenotype. All the tested Listeria species resisted the intestinal fluid. Gut microbial communities outcompeted and eliminated L. ivanovii and L. valentina. However, L. monocytogenes and L. seeligeri outcompeted intestinal commensal bacteria. Our findings suggest that, unlike L. monocytogenes and L. seeligeri, the tested L. ivanovii are unlikely to colonize the gastrointestinal tract of ruminants, which would reduce replication, fecal shedding, and environmental distribution. However, the ability of L. ivanovii to survive within uterine microbiota and semen suggests that the tested clones could persist in the urogenital tract of ruminants. Then venereal transmission could be more probable than the oral route, which could explain why L. ivanovii is associated with abortion outbreaks and not encephalitic cases.
{"title":"Tissue-specific microbiota dictates the competitive dynamics of <i>listeria</i> species colonization.","authors":"Juliette Poujol de Molliens, Carla Palacios-Gorba, Jazmin Meza-Torres, Jesús Gomis, Angel Gómez-Martín, Juan J Quereda","doi":"10.1080/01652176.2026.2622742","DOIUrl":"10.1080/01652176.2026.2622742","url":null,"abstract":"<p><p>The genus <i>Listeria</i> is heterogeneous and contains pathogenic and nonpathogenic species. Pathogenic <i>L. monocytogenes</i> and <i>L. ivanovii</i> have different environmental distributions, infect different hosts, and cause distinct syndromes. Here, we evaluated whether responses of different <i>Listeria</i> species to diverse host niches contribute to virulence heterogeneity and influence their environmental distribution. We assessed resistance to gastric and intestinal fluids, gut and uterus microbiota, and semen. <i>L. monocytogenes</i> was more resistant than <i>L. ivanovii</i> in gastric fluid, whilst <i>L. seeligeri</i> and <i>L. valentina</i> showed an intermediate phenotype. All the tested <i>Listeria</i> species resisted the intestinal fluid. Gut microbial communities outcompeted and eliminated <i>L. ivanovii</i> and <i>L. valentina</i>. However, <i>L. monocytogenes</i> and <i>L. seeligeri</i> outcompeted intestinal commensal bacteria. Our findings suggest that, unlike <i>L. monocytogenes</i> and <i>L. seeligeri</i>, the tested <i>L. ivanovii</i> are unlikely to colonize the gastrointestinal tract of ruminants, which would reduce replication, fecal shedding, and environmental distribution. However, the ability of <i>L. ivanovii</i> to survive within uterine microbiota and semen suggests that the tested clones could persist in the urogenital tract of ruminants. Then venereal transmission could be more probable than the oral route, which could explain why <i>L. ivanovii</i> is associated with abortion outbreaks and not encephalitic cases.</p>","PeriodicalId":51207,"journal":{"name":"Veterinary Quarterly","volume":"46 1","pages":"2622742"},"PeriodicalIF":5.2,"publicationDate":"2026-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12865829/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146101148","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}